TAAR1: A New Target With Therapeutic Potential for Psychiatric Conditions, Focus on Schizophrenia

episode

Keeping Current CME not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

recent transcribed audio

Oil Rises on Iran Tensions, US-China Tariffs Cut List, More 7 min · 28 Sep 2026 · Bloomberg News Now

1216: United States wins the 2026 Presidents Cup 1h 58m · 28 Sep 2026 · No Laying Up - Golf Podcast

NPR News: 09-27-2026 10PM EDT 5 min · 28 Sep 2026 · NPR News Now

Hormuz Stalemate, US-China Agree to Reciprocal Tariff Cuts, More 7 min · 28 Sep 2026 · Bloomberg News Now

Are the tides turning on Taylor Swift? 23 min · 28 Sep 2026 · The Moment with Myf Warhurst

10PM ET 09/27/2026 Newscast 3 min · 28 Sep 2026 · Fox News Hourly Update

Report any issue

Source

Recorded29 Nov 2022

Publisherkeepingcurrentcme.libsyn.com ↗

Handlerec:4299864

Show notes

Learn about the neuroscience driving the development of new therapies for schizophrenia. Credit available for this activity expires: 11/28/2023 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/984465?ecd=bdc_podcast_libsyn_mscpedu

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related